Abstract
Purpose
The concern of higher radiation exposure during cryoballoon ablation (CBA) compared with radiofrequency ablation for atrial fibrillation (AF) was raised before. Previously, we compared CBA plus intracardiac echocardiography (ICE) to our former standard approach without ICE. A substantial reduction of radiation exposure without compromising safety or outcome was observed. We now investigate if at all and possibly to which amount radiation reduction can be achieved with growing experience.
Methods
We retrospectively analysed procedure time, dose area product (DAP), fluoroscopy time (FT) and contrast media (CM) use for all patients receiving CBA between 2013 and 2017 for AF.
Results
In 1131 procedures, procedure time decreased significantly between 2013 and 2017 (2013 111 ± 26 min, 2017 99 ± 25 min, p = 0.005). DAP halved between 2013 and 2014 without further significant decline (2013 1428 ± 1276 cGycm2, 2014 725 ± 551 cGycm2, p < 0.001). FT demonstrated a constant decrease from 2013 to 2017 (2013 11.7 ± 5.5 min, 2017 5.1 ± 3.5 min, p < 0.001). CM use did not show a significant reduction comparing 2013 to 2017 (2013 62 ± 19 ml, 2017 59 ± 18 ml, 2013/2017 p = 0.584).
Conclusion
Given the imminent negative effects of radiation, every effort should be undertaken for its reduction. Feasible protocols can be kept simple by technical changes as reducing frame rates and basic radiation reduction strategies such as collimation, but ICE might add additional benefit. With growing experience and awareness of radioprotection, DAP and FT as low as or lower than in radiofrequency ablations seem possible.
Similar content being viewed by others
References
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.
Buiatti A, von Olshausen G, Barthel P, Schneider S, Luik A, Kaess B, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies. Europace. 2017;19:378–84.
Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.
Omran H, Gutleben KJ, Molatta S, Fischbach T, Wellmann B, Horstkotte D, et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol. 2018;107:182–92.
Straube F, Dorwarth UF, Ammar- Busch S, Peter T, Noelker G, Massa T, et al. First-line ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace. 2016;18:368–75.
Kuck K, Fürnkranz A, Chun JKR, Metzner A, Ouyang F, Schlüter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.
Heidbuchel H, Wittkampf FHM, Vano E, Ernst S, Schilling R, Picano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedure. Europace. 2014;16:946–64.
Nölker G, Heintze J, Gutleben KJ, Muntean B, Pütz V, Yalda A, et al. Cryoballoon pulmonary vein isolation supported by intracardiac echocardiography: integration of a nonfluoroscopic imaging technique in atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21:1325–30.
Schmidt M, Daccarett M, Marschang H, Ritscher G, Turschner O, Brachmann J, et al. Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardivasc Electrophysiol. 2010;21:1202–7.
Rubesch-Kütemeyer V, Molatta S, Vogt J, Gutleben KJ, Horstkotte D, Nölker G. Reduction of radiation exposure in cryoballoon ablation procedures: a single-centre study applying intracardiac echocardiography and other radioprotective measures. Europace. 2017;19:947–53.
Ector J, Dragusin O, Adriaenssens B, Huybrechts W, Willems R, Ector H, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2017;50:234–42.
Letsas KP, Siklódy CH, Korantzopoulos P, Weber R, Bürkle G, Mihas CC, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol. 2013;164:94–8.
Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423–7.
Tscholl V, Lsharaf AK, Lin T, Bellmann B, Biewener S, Nagel P, et al. Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm. 2016;13:1817–22.
Velagić V, de Asmundis C, Mugnai G, Hünük B, Hacioğlu E, Ströker E, et al. Learning curve using the second-generation cryoballoon ablation. J Cardiovasc Med. 2017;18:518–27.
Reissmann B, Maurer T, Wohlmuth P, Krüger M, Heeger C, Lemes C, et al. Significant reduction of radiation exposure in cryoballoon-based pulmonary vein isolation. Europace. 2018;20:608–13.
Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2014;25:1–7.
Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61:1707–12.
Haegeli LM, Stutz L, Mohsen M, Wolber T, Brunckhorst C, On, CJ, Duru F. Feasibility of zero or near zero fluoroscopy during catheter ablation procedures. Cardiol J https://doi.org/10.5603/CJ.a2018.0029, 2013.
Razminia M, Demo H, Arrieta-Garcia C, D’Silva OJ, Wang T, Kehoe RF. Nonfluoroscopic ablation of atrial fibrillation using cryoballoon. J Atr Fibrillation. 2014;7:1093.
Author information
Authors and Affiliations
Contributions
Concept/design (VRK, GN), data collection (VRK, TF, DG, BK), data analysis/interpretation (VRK, GN), statistics (VRK, GN), drafting article (VRK, GN), critical revision and approval of article (all authors).
Corresponding author
Ethics declarations
The study was approved by the institutional review board. Prior to ablation, all patients were selected according to the then current guidelines and written consent was obtained.
Conflict of interest
GN has received honoraria for lectures from Medtronic. The other authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rubesch-Kütemeyer, V., Fischbach, T., Guckel, D. et al. Long-term development of radiation exposure, fluoroscopy time and contrast media use in daily routine in cryoballoon ablations after implementation of intracardiac echocardiography and other radioprotective measures: experiences from a large single-centre cohort. J Interv Card Electrophysiol 58, 169–175 (2020). https://doi.org/10.1007/s10840-019-00564-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-019-00564-5